These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Ictal and interictal electroencephalographic findings can contribute to early diagnosis and prompt treatment in KCNQ2-associated epileptic encephalopathy. Lee IC; Chang MY; Liang JS; Chang TM J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):744-754. PubMed ID: 32863083 [TBL] [Abstract][Full Text] [Related]
23. Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2. Milh M; Boutry-Kryza N; Sutera-Sardo J; Mignot C; Auvin S; Lacoste C; Villeneuve N; Roubertie A; Heron B; Carneiro M; Kaminska A; Altuzarra C; Blanchard G; Ville D; Barthez MA; Heron D; Gras D; Afenjar A; Dorison N; Doummar D; Billette de Villemeur T; An I; Jacquette A; Charles P; Perrier J; Isidor B; Vercueil L; Chabrol B; Badens C; Lesca G; Villard L Orphanet J Rare Dis; 2013 May; 8():80. PubMed ID: 23692823 [TBL] [Abstract][Full Text] [Related]
26. Variable expressivity of a likely pathogenic variant in KCNQ2 in a three-generation pedigree presenting with intellectual disability with childhood onset seizures. Hewson S; Puka K; Mercimek-Mahmutoglu S Am J Med Genet A; 2017 Aug; 173(8):2226-2230. PubMed ID: 28602030 [TBL] [Abstract][Full Text] [Related]
27. Developmental and epilepsy spectrum of KCNB1 encephalopathy with long-term outcome. Bar C; Kuchenbuch M; Barcia G; Schneider A; Jennesson M; Le Guyader G; Lesca G; Mignot C; Montomoli M; Parrini E; Isnard H; Rolland A; Keren B; Afenjar A; Dorison N; Sadleir LG; Breuillard D; Levy R; Rio M; Dupont S; Negrin S; Danieli A; Scalais E; De Saint Martin A; El Chehadeh S; Chelly J; Poisson A; Lebre AS; Nica A; Odent S; Sekhara T; Brankovic V; Goldenberg A; Vrielynck P; Lederer D; Maurey H; Terrone G; Besmond C; Hubert L; Berquin P; Billette de Villemeur T; Isidor B; Freeman JL; Mefford HC; Myers CT; Howell KB; Rodríguez-Sacristán Cascajo A; Meyer P; Genevieve D; Guët A; Doummar D; Durigneux J; van Dooren MF; de Wit MCY; Gerard M; Marey I; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R Epilepsia; 2020 Nov; 61(11):2461-2473. PubMed ID: 32954514 [TBL] [Abstract][Full Text] [Related]
28. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. Kato M; Yamagata T; Kubota M; Arai H; Yamashita S; Nakagawa T; Fujii T; Sugai K; Imai K; Uster T; Chitayat D; Weiss S; Kashii H; Kusano R; Matsumoto A; Nakamura K; Oyazato Y; Maeno M; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Saito K; Hayasaka K; Matsumoto N; Saitsu H Epilepsia; 2013 Jul; 54(7):1282-7. PubMed ID: 23621294 [TBL] [Abstract][Full Text] [Related]
29. Epilepsy phenotype and response to KCNQ openers in mice harboring the Kcnq2 R207W voltage-sensor mutation. Tian F; Cao B; Xu H; Zhan L; Nan F; Li N; Taglialatela M; Gao Z Neurobiol Dis; 2022 Nov; 174():105860. PubMed ID: 36113748 [TBL] [Abstract][Full Text] [Related]
30. Antiepileptic therapy approaches in KCNQ2 related epilepsy: A systematic review. Kuersten M; Tacke M; Gerstl L; Hoelz H; Stülpnagel CV; Borggraefe I Eur J Med Genet; 2020 Jan; 63(1):103628. PubMed ID: 30771507 [TBL] [Abstract][Full Text] [Related]
31. Genotype-phenotype correlates of infantile-onset developmental & epileptic encephalopathy syndromes in South India: A single centre experience. Mitta N; Menon RN; McTague A; Radhakrishnan A; Sundaram S; Cherian A; Madhavilatha GK; Mannan AU; Nampoothiri S; Thomas SV Epilepsy Res; 2020 Oct; 166():106398. PubMed ID: 32593896 [TBL] [Abstract][Full Text] [Related]
32. Generalized tonic seizures with autonomic signs are the hallmark of SCN8A developmental and epileptic encephalopathy. Trivisano M; Pavia GC; Ferretti A; Fusco L; Vigevano F; Specchio N Epilepsy Behav; 2019 Jul; 96():219-223. PubMed ID: 31174070 [TBL] [Abstract][Full Text] [Related]
33. Neurodevelopmental outcomes in a cohort of Australian families with self-limited familial epilepsy of neonatal/infantile onset. Innes EA; Marne FAL; Macintosh R; Nevin SM; Briggs NE; Vivekanandarajah S; Webster RI; Sachdev RK; Bye AME Seizure; 2024 Feb; 115():1-13. PubMed ID: 38160512 [TBL] [Abstract][Full Text] [Related]
39. Pyridoxine-responsive KCNQ2 epileptic encephalopathy: Additional cases and literature review. Chen J; Tao Q; Fan L; Shen Y; Liu J; Luo H; Yang Z; Liang M; Gan J Mol Genet Genomic Med; 2022 Oct; 10(10):e2024. PubMed ID: 35906921 [TBL] [Abstract][Full Text] [Related]
40. CASK related disorder: Epilepsy and developmental outcome. Giacomini T; Nuovo S; Zanni G; Mancardi MM; Cusmai R; Pepi C; Bertini E; Valente EM; Battini R; Ferrari A; Romaniello R; Zucca C; Borgatti R; Uccella S; Severino M; Striano P; Pistorio A; Prato G; De Grandis E; Nobili L; Pisciotta L Eur J Paediatr Neurol; 2021 Mar; 31():61-69. PubMed ID: 33640666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]